Temat: "B7-H1 Antigen" - OpacWWW

Skocz do pozycji: 61.

Tytuł:: Detailed Characterization of the Lung-Gut Microbiome Axis Reveals the Link between PD-L1 and the Microbiome in Non-Small-Cell Lung Cancer Patients.
Autorzy:: Ankudavicius V; Department of Pulmonology, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Nikitina D; Institute for Digestive Research, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Lukosevicius R; Institute for Digestive Research, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Tilinde D; Institute for Digestive Research, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Salteniene V; Institute for Digestive Research, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Poskiene L; Department of Pathology, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Miliauskas S; Department of Pulmonology, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Skieceviciene J; Institute for Digestive Research, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Zemaitis M; Department of Pulmonology, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Kupcinskas J; Institute for Digestive Research, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.; Department of Gastroenterology, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 15; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/microbiology
Carcinoma, Non-Small-Cell Lung*/pathology
Gastrointestinal Microbiome*
Lung*/microbiology
Lung*/pathology
Lung Neoplasms*/microbiology
Humans ; B7-H1 Antigen/genetics ; B7-H1 Antigen/analysis ; RNA, Ribosomal, 16S/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 62.

Tytuł:: Comparison of genomic alterations in Epstein-Barr virus-positive and Epstein-Barr virus-negative diffuse large B-cell lymphoma.
Autorzy:: Liu F; Department of Pathology, The First People's Hospital of Foshan, Foshan, Guangdong, China.
Tian S; Department of Pathology and Molecular Diagnostics, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, China.
Liu Q; Department of Pathology, The First People's Hospital of Foshan, Foshan, Guangdong, China.
Deng Y; Department of Pathology, The First People's Hospital of Foshan, Foshan, Guangdong, China.
He Q; Department of Pathology, The First People's Hospital of Foshan, Foshan, Guangdong, China.
Shi Q; Department of Pathology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China.
Chen G; Department of Pathology, Fujian Province Cancer Center, Fuzhou, Fujian, China.
Xu X; State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shannxi, China.
Yuan J; Department of Pathology, The First People's Hospital of Foshan, Foshan, Guangdong, China.
Nakamura S; Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan.
Karube K; Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan.
Wang Z; State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shannxi, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e6995.
Typ publikacji:: Journal Article
MeSH Terms:: Epstein-Barr Virus Infections*/complications
Epstein-Barr Virus Infections*/genetics
Epstein-Barr Virus Infections*/pathology
Lymphoma, Large B-Cell, Diffuse*/pathology
Humans ; Herpesvirus 4, Human/genetics ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Genomics ; Intracellular Signaling Peptides and Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 63.

Tytuł:: The association of genomic alterations with PD-L1 expression in Chinese patients with EGFR/ALK wild-type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy.
Autorzy:: Liu F; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang X; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Lu M; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu C; Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
Zhang X; Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen Y; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang P; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e7038.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/therapy
Lung Neoplasms*/therapy
Lung Neoplasms*/drug therapy
Humans ; Anaplastic Lymphoma Kinase/genetics ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; CD8-Positive T-Lymphocytes/metabolism ; China ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Genomics ; Hippo Signaling Pathway/genetics ; Immunotherapy ; Mutation ; Retrospective Studies ; Tumor Microenvironment/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 64.

Tytuł:: Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma".
Autorzy:: Shigeta N; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Yokose T; Department of Pathology, Kanagawa Cancer Center, Yokohama, Japan.
Murakami S; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Isaka T; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Shinada K; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Yoshioka E; Department of Pathology, Kanagawa Cancer Center, Yokohama, Japan.
Narita A; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Katakura K; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Kondo T; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Kato T; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Nagashima T; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Saito H; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Ito H; Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (6), pp. 458-465. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma*/diagnosis
Adenocarcinoma*/genetics
Adenocarcinoma*/metabolism
Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/metabolism
Carcinoma, Squamous Cell*/diagnosis
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/metabolism
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Humans ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; ErbB Receptors/genetics ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 65.

Tytuł:: Evaluation of Molecular-level Changes of Programmed Cell Death Ligand-1 after Radiation Therapy in a BALB/c CT26 Colorectal Mouse Tumor Model.
Autorzy:: Khani Chamani F; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Shabani M; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Moradi A; Department of Pathology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Alinejad M; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Jalali SA; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .; Pokaż więcej
Źródło:: Iranian journal of allergy, asthma, and immunology [Iran J Allergy Asthma Immunol] 2023 Apr 30; Vol. 22 (2), pp. 163-171. Date of Electronic Publication: 2023 Apr 30.
Typ publikacji:: Journal Article
MeSH Terms:: B7-H1 Antigen*/genetics
B7-H1 Antigen*/metabolism
Colorectal Neoplasms*/radiotherapy
Animals ; Mice ; Female ; Mice, Inbred BALB C ; Ligands ; Apoptosis ; Cell Line, Tumor ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 66.

Tytuł:: A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer.
Autorzy:: Mayoh C; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.; University of New South Wales Centre for Childhood Cancer Research, UNSW, Kensington, NSW, Australia.
Gifford AJ; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.; Anatomical Pathology, NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW, Australia.
Terry R; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.
Lau LMS; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.
Wong M; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.
Rao P; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.
Shai-Hee T; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.
Saletta F; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.
Khuong-Quang DA; Children's Cancer Centre, Royal Children's Hospital, Parkville, VIC, Australia.; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
Qin V; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
Mateos MK; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.
Meyran D; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
Miller KE; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.
Yuksel A; Tumour Bank, Children's Hospital Westmead, Westmead, NSW, Australia.
Mould EVA; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.
Bowen-James R; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Computer Science and Engineering, UNSW Sydney, Kensington, NSW, Australia.; School of Biomedical Engineering, UNSW Sydney, Kensington, NSW, Australia.
Govender D; Cancer Centre for Children, Children's Hospital Westmead, Westmead, NSW, Australia.
Senapati A; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.
Zhukova N; Monash Children's Hospital, Melbourne, VIC, Australia.; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Paediatrics, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
Omer N; Oncology Service, Children's Health Queensland Hospital & Health Service, Brisbane, QLD, Australia.; The University of Queensland Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Dholaria H; Department of Paediatric and Adolescent Oncology and Haematology, Perth Children's Hospital, Nedlands, WA, Australia.; Brain Tumour Research Program, Telethon Kids Institute, Nedlands, WA, Australia.
Alvaro F; John Hunter Children's Hospital, New Lambton Heights, NSW, Australia.
Tapp H; Michael Rice Cancer Centre, Women's and Children's Hospital, South Australia Health and Medical Research Institute, Adelaide, SA, Australia.
Diamond Y; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.; Children's Cancer Centre, Royal Children's Hospital, Parkville, VIC, Australia.
Pozza LD; Cancer Centre for Children, Children's Hospital Westmead, Westmead, NSW, Australia.
Moore AS; Oncology Service, Children's Health Queensland Hospital & Health Service, Brisbane, QLD, Australia.; Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia.
Nicholls W; Oncology Service, Children's Health Queensland Hospital & Health Service, Brisbane, QLD, Australia.; School of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Gottardo NG; Department of Paediatric and Adolescent Oncology and Haematology, Perth Children's Hospital, Nedlands, WA, Australia.; Brain Tumour Research Program, Telethon Kids Institute, Nedlands, WA, Australia.
McCowage G; Cancer Centre for Children, Children's Hospital Westmead, Westmead, NSW, Australia.
Hansford JR; Michael Rice Cancer Centre, Women's and Children's Hospital, South Australia Health and Medical Research Institute, Adelaide, SA, Australia.; South Australia ImmunoGENomics Cancer Institute, University of Adelaide, Adelaide, SA, Australia.
Khaw SL; Children's Cancer Centre, Royal Children's Hospital, Parkville, VIC, Australia.; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
Wood PJ; Monash Children's Hospital, Melbourne, VIC, Australia.; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Paediatrics, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
Catchpoole D; Tumour Bank, Children's Hospital Westmead, Westmead, NSW, Australia.
Cottrell CE; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.; Department of Pathology, The Ohio State University College of Medicine, Columbus, OH, USA.
Mardis ER; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.; Department of Neurosurgery, The Ohio State University College of Medicine, Columbus, OH, USA.
Marshall GM; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.
Tyrrell V; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.
Haber M; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.
Ziegler DS; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.
Vittorio O; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.
Trapani JA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
Cowley MJ; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.
Neeson PJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
Ekert PG; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia. .; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia. .; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia. .; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia. .; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia. .; Pokaż więcej
Źródło:: Genome medicine [Genome Med] 2023 Apr 03; Vol. 15 (1), pp. 20. Date of Electronic Publication: 2023 Apr 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: B7-H1 Antigen*/genetics
B7-H1 Antigen*/metabolism
Neoplasms*/genetics
Adult ; Humans ; Child ; CD8-Positive T-Lymphocytes/metabolism ; Biomarkers, Tumor/genetics ; Tumor Microenvironment/genetics ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 67.

Tytuł:: The Regulatory Axis of PD-L1 Isoform 2/TNF/T Cell Proliferation Is Required for the Canonical Immune-Suppressive Effects of PD-L1 Isoform 1 in Liver Cancer.
Autorzy:: Zheng X; State Key Laboratory of Genetic Engineering, Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai 200438, China.
Chen X; State Key Laboratory of Genetic Engineering, Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai 200438, China.; Taizhou Institute of Health Sciences, Fudan University, Taizhou 225316, China.
Wu W; State Key Laboratory of Genetic Engineering, Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai 200438, China.; Rugao Joint Research Institute of Longevity and Aging, Fudan University, Rugao 226599, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Mar 28; Vol. 24 (7). Date of Electronic Publication: 2023 Mar 28.
Typ publikacji:: Journal Article
MeSH Terms:: B7-H1 Antigen*/genetics
B7-H1 Antigen*/metabolism
Liver Neoplasms*/genetics
Humans ; Cell Proliferation/genetics ; Immunosuppression Therapy ; Ligands ; Protein Isoforms/genetics ; Protein Isoforms/metabolism ; Tumor Microenvironment/genetics ; Tumor Necrosis Factors/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 68.

Tytuł:: Characterisation of tumor microenvironment and prevalence of CD274/PD-L1 genetic alterations difference in colorectal Cancer.
Autorzy:: Yang L; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 Baiyun Avenue North, Guangzhou, 510515, China.
Liu S; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng Road east, Guangzhou, 510060, China.; Department of General Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng Road east, Guangzhou, 510060, China.
He W; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng Road east, Guangzhou, 510060, China.; Department of General Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng Road east, Guangzhou, 510060, China.
Xiong Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng Road east, Guangzhou, 510060, China. .; Department of Breast Oncology, Sun Yat-sen University Cancer Center, 651 Dongfeng Road east, Guangzhou, 510060, China. .
Xia L; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng Road east, Guangzhou, 510060, China. .; Department of General Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng Road east, Guangzhou, 510060, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Mar 09; Vol. 23 (1), pp. 221. Date of Electronic Publication: 2023 Mar 09.
Typ publikacji:: Journal Article
MeSH Terms:: B7-H1 Antigen*/genetics
B7-H1 Antigen*/metabolism
Colorectal Neoplasms*/epidemiology
Colorectal Neoplasms*/genetics
Humans ; Tumor Microenvironment/genetics ; In Situ Hybridization, Fluorescence ; Prevalence ; DNA Mismatch Repair/genetics
SCR Disease Name:: Turcot syndrome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 69.

Tytuł:: Radiotherapy combined with anti-PD-1 and TKI for primary cardiac angiosarcoma considering the joint assessment of TLSs and PD-L1: a case report.
Autorzy:: Deng S; Department of Pathology, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150086, China.
Yang X; Precision Medical Center, Harbin Medical University Cancer Hospital, Harbin, China.
He L; Department of stomatology, Heilongjiang provincial hospital, Harbin, China.
Zhang Q; Department of Abdominal Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
Zhao C; Department of Gastrointestinal Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Meng H; Department of Pathology, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150086, China. .; Pokaż więcej
Źródło:: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Apr 09; Vol. 19 (1), pp. 194. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Tertiary Lymphoid Structures*
Hemangiosarcoma*/diagnosis
Hemangiosarcoma*/therapy
Lung Neoplasms*/pathology
Male ; Humans ; Middle Aged ; B7-H1 Antigen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 70.

Tytuł:: An AI-based approach for modeling the synergy between radiotherapy and immunotherapy.
Autorzy:: Peng H; Departments of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA. .; Medical Artificial Intelligence and Automation Laboratory, University of Texas Southwestern Medical Center, Dallas, TX, USA. .
Moore C; Departments of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Zhang Y; Departments of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Saha D; Departments of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Jiang S; Departments of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Medical Artificial Intelligence and Automation Laboratory, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Timmerman R; Departments of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 08; Vol. 14 (1), pp. 8250. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article
MeSH Terms:: DEAE-Dextran*
Radiosurgery*
Animals ; Mice ; Immunotherapy/methods ; Neural Networks, Computer ; Combined Modality Therapy ; B7-H1 Antigen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 71.

Tytuł:: PD-1/PD-L1 axis induced host immunosuppression via PI3K/Akt/mTOR signalling pathway in piglets infected by Glaesserella Parasuis.
Autorzy:: Li J; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Liu S; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Dong Q; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Fu Y; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Sun Y; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Luo R; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Tian X; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Guo L; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Liu W; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Qiu Y; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Lu Q; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Ye C; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Zong B; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China.; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China.
Fu S; Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, 430023, PR China. .; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, 430023, PR China. .; Pokaż więcej
Źródło:: BMC veterinary research [BMC Vet Res] 2024 Apr 06; Vol. 20 (1), pp. 141. Date of Electronic Publication: 2024 Apr 06.
Typ publikacji:: Randomized Controlled Trial, Veterinary; Journal Article
MeSH Terms:: Haemophilus parasuis*
Haemophilus Infections*/microbiology
Haemophilus Infections*/veterinary
Swine Diseases*/microbiology
Animals ; Swine ; Proto-Oncogene Proteins c-akt ; Programmed Cell Death 1 Receptor ; Phosphatidylinositol 3-Kinases ; B7-H1 Antigen ; TOR Serine-Threonine Kinases ; Immunosuppression Therapy/veterinary

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 72.

Tytuł:: PD-L1 Expression in Ampullary Adenocarcinoma.
Autorzy:: Siddiqui SH; Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Kumari N; Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India.
Mishra S; Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Radha P; Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Mohindra S; Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Singh RK; Department of Surgical Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Krishnani N; Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.; Pokaż więcej
Źródło:: International journal of surgical pathology [Int J Surg Pathol] 2024 Apr; Vol. 32 (2), pp. 263-272. Date of Electronic Publication: 2023 Jun 08.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*
Adenocarcinoma*/drug therapy
Duodenal Neoplasms*/drug therapy
Pancreatic Neoplasms*
Common Bile Duct Neoplasms*
Male ; Humans ; Female ; B7-H1 Antigen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 73.

Tytuł:: Self-delivery photothermal-boosted-nanobike multi-overcoming immune escape by photothermal/chemical/immune synergistic therapy against HCC.
Autorzy:: Yang H; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China.
Mu W; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China.
Yuan S; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China.
Yang H; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China.
Chang L; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China.
Sang X; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China.
Gao T; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China.
Liang S; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China.
Liu X; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China.
Fu S; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China.
Zhang Z; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China.
Liu Y; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China. .
Zhang N; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Mar 29; Vol. 22 (1), pp. 137. Date of Electronic Publication: 2024 Mar 29.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/metabolism
Liver Neoplasms*/metabolism
Animals ; Mice ; B7-H1 Antigen/metabolism ; Photothermal Therapy ; Sorafenib/pharmacology ; Cell Line, Tumor ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 74.

Tytuł:: Comparing deep learning and pathologist quantification of cell-level PD-L1 expression in non-small cell lung cancer whole-slide images.
Autorzy:: van Eekelen L; Department of Pathology, Radboud University Medical Center, P.O.Box 9101, 6500 HB, Nijmegen, The Netherlands. .
Spronck J; Department of Pathology, Radboud University Medical Center, P.O.Box 9101, 6500 HB, Nijmegen, The Netherlands.
Looijen-Salamon M; Department of Pathology, Radboud University Medical Center, P.O.Box 9101, 6500 HB, Nijmegen, The Netherlands.
Vos S; Department of Pathology, Radboud University Medical Center, P.O.Box 9101, 6500 HB, Nijmegen, The Netherlands.
Munari E; Pathology Unit, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Girolami I; Department of Pathology, Provincial Hospital of Bolzano (SABES-ASDAA), Bolzano-Bozen, Italy.
Eccher A; Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy.
Acs B; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
Boyaci C; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
de Souza GS; Department of Pathology, Radboud University Medical Center, P.O.Box 9101, 6500 HB, Nijmegen, The Netherlands.
Demirel-Andishmand M; Department of Pathology, Radboud University Medical Center, P.O.Box 9101, 6500 HB, Nijmegen, The Netherlands.
Meesters LD; Department of Pathology, Radboud University Medical Center, P.O.Box 9101, 6500 HB, Nijmegen, The Netherlands.
Zegers D; Department of Pathology, Radboud University Medical Center, P.O.Box 9101, 6500 HB, Nijmegen, The Netherlands.
van der Woude L; Department of Pathology, Radboud University Medical Center, P.O.Box 9101, 6500 HB, Nijmegen, The Netherlands.
Theelen W; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
van den Heuvel M; Respiratory Diseases Department, Radboud University Medical Center, Nijmegen, The Netherlands.
Grünberg K; Department of Pathology, Radboud University Medical Center, P.O.Box 9101, 6500 HB, Nijmegen, The Netherlands.
van Ginneken B; Department of Radiology, Radboud University Medical Center, Nijmegen, The Netherlands.
van der Laak J; Department of Pathology, Radboud University Medical Center, P.O.Box 9101, 6500 HB, Nijmegen, The Netherlands.
Ciompi F; Department of Pathology, Radboud University Medical Center, P.O.Box 9101, 6500 HB, Nijmegen, The Netherlands.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 26; Vol. 14 (1), pp. 7136. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Deep Learning*
Humans ; Pathologists ; B7-H1 Antigen/metabolism ; Immunohistochemistry ; Biomarkers, Tumor/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 75.

Tytuł:: Camptothecin enhances the anti-tumor effect of low-dose apatinib combined with PD-1 inhibitor on hepatocellular carcinoma.
Autorzy:: Wang H; Department of Radiology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, 250000, People's Republic of China.
Gao C; Jinan Center for Disease Control and Prevention, Jinan, Shandong, 250000, People's Republic of China.
Li X; Department of Radiology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, 250000, People's Republic of China.
Chen F; Department of Radiology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, 250000, People's Republic of China. .; Department of Radiology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, 16766 Jingshi Road, Lixia, Jinan, Shandong, 250014, People's Republic of China. .
Li G; Department of Radiology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, 16766 Jingshi Road, Lixia, Jinan, Shandong, 250014, People's Republic of China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 26; Vol. 14 (1), pp. 7140. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Pyridines*
Animals ; Mice ; Vascular Endothelial Growth Factor A/metabolism ; B7-H1 Antigen/metabolism ; Immune Checkpoint Inhibitors/therapeutic use ; Programmed Cell Death 1 Receptor/metabolism ; NF-E2-Related Factor 2 ; Camptothecin/therapeutic use ; Cell Line, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 76.

Tytuł:: CDKL1 potentiates the antitumor efficacy of radioimmunotherapy by binding to transcription factor YBX1 and blocking PD-L1 expression in lung cancer.
Autorzy:: Li Z; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, China.
Xue H; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, China.
Li J; Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Zheng Z; Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Liu Z; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, China.
Dong X; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, China.
Wang H; Clinical Research Center of Cancer Immunotherapy, Wuhan, 430022, China.
Chen J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .; Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, China. .
Xu S; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .; Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, China. .; Clinical Research Center of Cancer Immunotherapy, Wuhan, 430022, China. .; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 22; Vol. 43 (1), pp. 89. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/drug therapy
Humans ; Animals ; Mice ; Transcription Factors ; CD8-Positive T-Lymphocytes/metabolism ; B7-H1 Antigen/metabolism ; Radioimmunotherapy ; Mice, Inbred C57BL ; Cell Line, Tumor ; Nerve Tissue Proteins/metabolism ; Cyclin-Dependent Kinases/metabolism ; Y-Box-Binding Protein 1

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 77.

Tytuł:: Differential Expression of CKLF-like MARVEL Transmembrane Domain-Containing Protein 6 and Programmed Cell Death Ligand 1 as Prognostic Biomarkers in Upper Tract Urothelial Carcinoma.
Autorzy:: Kdimati S; Institute of Pathology, Rostock University Medical Center, 18057 Rostock, Germany.
Christoph C; Institute of Pathology, Rostock University Medical Center, 18057 Rostock, Germany.
Glass Ä; Institute of Biostatistics and Informatics in Medicine and Aging Research, Rostock University Medical Center, 18057 Rostock, Germany.
Engel N; Department of Oral, Maxillofacial and Plastic Surgery, Rostock University Medical Center, 18057 Rostock, Germany.
Dräger DL; Department of Urology, Rostock University Medical Center, 18057 Rostock, Germany.
Maletzki C; Department of Internal Medicine, Medical Clinic III-Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, 18057 Rostock, Germany.
Becker AS; Institute of Pathology, Rostock University Medical Center, 18057 Rostock, Germany.
Zimpfer A; Institute of Pathology, Rostock University Medical Center, 18057 Rostock, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 20; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Transitional Cell*/metabolism
Urinary Bladder Neoplasms*
Humans ; B7-H1 Antigen ; Prognosis ; Retrospective Studies ; Ligands ; Apoptosis ; Biomarkers ; Chemokines ; MARVEL Domain-Containing Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 78.

Tytuł:: Association of lymphocyte subsets with the efficacy and prognosis of PD‑1 inhibitor therapy in advanced gastric cancer: results from a monocentric retrospective study.
Autorzy:: Wang X; The First Clinical Medical College of Shanxi Medical University, No.56, Xinjian South Road, Yingze District, Taiyuan, Shanxi, 030001, People's Republic of China.; Department of Oncology, The First Hospital of Shanxi Medical University, No.85, Jiefang South Road, Yingze District, Taiyuan, Shanxi, 030001, People's Republic of China.
Liu X; Department of Special Medical, Shanxi Province Cancer Hospital, Taiyuan, Shanxi, 030013, China.
Dai H; The Second Clinical Medical College of Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Jia J; Department of Oncology, The First Hospital of Shanxi Medical University, No.85, Jiefang South Road, Yingze District, Taiyuan, Shanxi, 030001, People's Republic of China. .; Pokaż więcej
Źródło:: BMC gastroenterology [BMC Gastroenterol] 2024 Mar 15; Vol. 24 (1), pp. 113. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:: Journal Article
MeSH Terms:: Immune Checkpoint Inhibitors*
Stomach Neoplasms*/drug therapy
Humans ; B7-H1 Antigen ; Retrospective Studies ; Prognosis ; Lymphocyte Subsets

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 79.

Tytuł:: Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC.
Autorzy:: de Miguel-Perez D; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.
Ak M; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Mamindla P; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Russo A; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Medical Oncology Unit, A.O. Papardo & Department of Human Pathology, University of Messina, Messina, Italy.
Zenkin S; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Ak N; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Peddagangireddy V; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Lara-Mejia L; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.
Gunasekaran M; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Departments of Surgery and Pediatrics, Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, IL, USA.
Cardona AF; Molecular Oncology and Biology Systems Research Group (Fox G), Universidad El Bosque, Bogota, Colombia.
Naing A; Departments of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hirsch FR; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.
Arrieta O; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.
Colen RR; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Rolfo C; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 15; Vol. 43 (1), pp. 81. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:: Letter
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/drug therapy
Extracellular Vesicles*/pathology
Humans ; B7-H1 Antigen/therapeutic use ; Radiomics ; Multiomics ; Prospective Studies ; Biomarkers, Tumor ; Immunotherapy

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 80.

Tytuł:: The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling.
Autorzy:: Li T; Department of Gynecology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310009, People's Republic of China.; Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, China.
Niu M; Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Science, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Zhou J; Department of Gynecology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310009, People's Republic of China.; Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, China.
Wu K; Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Science, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China. .
Yi M; Department of Breast Surgery, College of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, 310000, People's Republic of China. mingyi_.; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Mar 12; Vol. 22 (1), pp. 179. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibodies, Bispecific*/therapeutic use
Neoplasms*/therapy
Programmed Cell Death 1 Receptor*/antagonists & inhibitors
Humans ; B7-H1 Antigen ; Signal Transduction ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""B7-H1 Antigen"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język